CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 37 enrolled
Drug / intervention
Paroxetine +1 moredrug
Likely dose
Paroxetine 50 milligramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01130103
NCT01130103Phase 4Completed
CompareCT.gov

Combination Treatment for PTSD After the WTC Attack

Research Foundation for Mental Hygiene, Inc.·interventional·Posted May 25, 2010·Updated Dec 4, 2012

In Brief

A Phase 4 clinical trial evaluating Paroxetine and Prolonged Exposure Therapy for Posttraumatic Stress Disorder. Completed, enrolled 37 participants across 1 site.

Detailed Summary

This randomized controlled trial evaluates efficacy of combined prolonged exposure (PE) and the selective serotonin reuptake inhibitor (SSRI) paroxetine in the treatment of survivors of the World Trade Center (WTC) attacks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPosttraumatic Stress Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 25, 2010
Enrollment StartMar 1, 2004
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 16.1 years ago

Interventions

Paroxetinedrug

Paroxetine (controlled release) 12.5-50 milligrams (mg) daily for 22 weeks

Prolonged Exposure Therapybehavioral

Weekly for 10 weeks